Jasper Therapeutics Announces 1-for-30 Reverse Stock Split

Jasper Therapeutics announced a 1-for-30 reverse stock split of its common stock, effective November 6, 2026. This action will reduce the number of outstanding shares from approximately 33.3 million to 1.11 million, aiming to increase the per-share price and potentially maintain its Nasdaq listing. The company's stock will continue trading under the JSPR symbol with a new CUSIP number.